Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSABP C-02: Postoperative Portal Vein Infusion of 5-Fluorouracil and Heparin in Colon Cancer
NCT00427310Phase 3
Key facts
- Status
- Completed
- Start
- Mar 1984
- Primary completion
- Sep 1989
- Sponsor
- NSABP Foundation
- Modality
- Small Molecules
- Drugs
- fluorouracil
- Conditions
- colon adenocarcinoma
01
Overview
Phase 3, randomised, open-label trial in colon adenocarcinoma comparing 5-FU + Heparin with Observation (2 arms). Primary endpoints: Disease Free Interval at 4 years and Overall Survival at 4 years. Started Mar 1984; status: completed.
02
Design
2 arms- Study design
- RandomizedOpen-label
5-FU + Heparin
Portal vein infusion of 5-Fluorouracil and Sodium Heparin
Observation
No further treatment
03
Endpoints
Primary
Disease Free Interval
Overall Survival
Beyond the preview
Go deeper on NCT00427310.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427310.